Alphatec opened higher at $7.40, compared with its previous close of $7.35. In the last trading session, the stock traded between $7.01 and $7.44. It showed a downward intraday trend.
Return calculator
Time Period
An investment of $100 made 5 years ago in Alphatec is now worth
$ 60.49
Resulting in a loss of
$ 39.51 (39.51%)
Invest with $1
Note: Past profits do not guarantee future returns.
Analyst Overview
Rating from 10 Analysts
Buy
80%
Hold
20%
Sell
0%
Markets Today
Today's Change
$-0.29 (-3.88%)
Day High
$7.44
Day Low
$7.01
Day Open
$7.40
Prev Close
$7.35
Volume
47,30,513
1W Return
-14.68%
1M Return
-37.23%
3M Return
-24.54%
6M Return
1.07%
1Y Return
-65.90%
Fundamentals
Market Cap ($ Mn)
1,096
PE Ratio
-
PB Ratio
-
PEG Ratio
-
ROE
-
ROCE
-16.11%
EPS (TTM)
$-0.04
Investment Returns
1 Week
-14.68%
1 Month
-37.23%
3 Months
-24.54%
6 Months
1.07%
9 Months
-47.55%
Financials
Quarterly
All values in $ Mn
185.5
Jun 25
196.5
Sep 25
212.9
Dec 25
192.1
Mar 26
213.5
Jun 26
221.2
Sep 26
Updates
12Nov
Alphatec Holdings schedules investor meetings for December 2026
Management attends Piper Sandler Healthcare Conference on December 1, 2026. Presentation scheduled at Stifel West Coast Med-Tech Bus Tour on December 7, 2026. Board approved 87 grants totaling 243,089 RSUs for new non-executive employees. RSUs vest annually over four years or fully upon change of control.
Yesterday
11Nov
Freedom Capital maintains Buy on Alphatec Holdings, cuts target to $12
Freedom Capital Markets maintained a Buy rating on Alphatec Holdings. Price target lowered from $17 to $12 by analyst Keith Hinton. Rating action reflects updated valuation assumptions.
Yesterday
5Nov
UBS downgrades Alphatec Holdings to Neutral, cuts price target to $8.50
UBS downgraded Alphatec Holdings from Buy to Neutral. Price target lowered from $15 to $8.50. Analyst Patrick Wood issued the revised rating and target.
8 days ago
4Nov
Levi & Korsinsky probes Alphatec over undisclosed supply constraints
Levi & Korsinsky opens investigation into Alphatec Holdings over securities law claims. Probe focuses on non-disclosure of international supply constraints before guidance cut. FY26 revenue guidance reduced twice, totaling $28 million decrease to $862 million. Shareholders who purchased stock and suffered losses are eligible for review.
8 days ago
20Oct
Alphatec Holdings sets October 29 for Q3FY26 results release
Alphatec Holdings to report Q3FY26 results on October 29, 2026. Webcast scheduled for 1:30 pm PT / 4:30 pm ET. Analysts must register in advance for Q&A session. Replay available for 12 months on IR website.
24 days ago
24Sep
Alphatec Holdings appoints Tommy Carls as EVP, Data Intelligence and Strategy
Alphatec Holdings appointed Thomas "Tommy" Carls as Executive Vice President, Data Intelligence and Strategy. Carls reports directly to Chairman and CEO Pat Miles and joins the Senior Leadership Team. Role focuses on advancing the InformatiX strategy across EOSedge, EOS Insight, and analytics. Carls brings 30+ years of experience and holds more than 80 patents in medical technology.
